Cited by 225Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis

Open access

McIntyre, William F., Um, Kevin J., Alhazzani, Waleed, Lengyel, Alexandra P., Hajjar, Ludhmila, Gordon, Anthony C., Lamontagne, François, Healey, Jeff S., Whitlock, Richard P., Belley-Côté, Emilie P.·2018·JAMA

DOI 10.1001/jama.2018.4528PMC PMC6583502

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Vasopressin is an alternative to catecholamine vasopressors for patients with distributive shock-a condition due to excessive vasodilation, most frequently from severe infection. Blood pressure support with a noncatecholamine vasopressor may reduce stimulation of adrenergic receptors and decrease myocardial oxygen demand. Atrial fibrillation is common with catecholamines and is associated with adverse events, including mortality and increased length of stay (LOS). Objectives: To determine whether treatment with vasopressin + catecholamine vasopressors compared with catecholamine vasopressors alone was associated with reductions in the risk of adverse events. Data Sources: MEDLINE, EMBASE, and CENTRAL were searched from inception to February 2018. Experts were asked and meta-registries searched to identify ongoing trials. Study Selection: Pairs of reviewers identified randomized clinical trials comparing vasopressin in combination with catecholamine vasopressors to catecholamines alone for patients with distributive shock. Data Extraction and Synthesis: Two reviewers abstracted data independently. A random-effects model was used to combine data. Main Outcomes and Measures: The primary outcome was atrial fibrillation. Other outcomes included mortality, requirement for renal replacement therapy (RRT), myocardial injury, ventricular arrhythmia, stroke, and LOS in the intensive care unit and hospital. Measures of association are reported as risk ratios (RRs) for clinical outcomes and mean differences for LOS. Results: Twenty-three randomized clinical trials were identified (3088 patients; mean age, 61.1 years [14.2]; women, 45.3%). High-quality evidence supported a lower risk of atrial fibrillation associated with vasopressin treatment (RR, 0.77 [95% CI, 0.67 to 0.88]; risk difference [RD], -0.06 [95% CI, -0.13 to 0.01]). For mortality, the overall RR estimate was 0.89 (95% CI, 0.82 to 0.97; RD, -0.04 [95% CI, -0.07 to 0.00]); however, when limited to trials at low risk of bias, the RR estimate was 0.96 (95% CI, 0.84 to 1.11). The overall RR estimate for RRT was 0.74 (95% CI, 0.51 to 1.08; RD, -0.07 [95% CI, -0.12 to -0.01]). However, in an analysis limited to trials at low risk of bias, RR was 0.70 (95% CI, 0.53 to 0.92, P for interaction = .77). There were no significant differences in the pooled risks for other outcomes. Conclusions and Relevance: In this systematic review and meta-analysis, the addition of vasopressin to catecholamine vasopressors compared with catecholamines alone was associated with a lower risk of atrial fibrillation. Findings for secondary outcomes varied.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2018.4528

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citation
Circulatory Shock
Vincent, J., & Backer, D. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,532
The Pathogenesis of Vasodilatory Shock
Landry, D. W., & Oliver, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002709 · Cited by 1,144
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.10485 · Cited by 728
Self-citation

Show all 45 references

Sorted by citations

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citation
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citation
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Self-citation
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Alhazzani, W. A., Møller, M. H., Arabi, Y. M., Loeb, M. B., Gong, M. N., Fan, E., Oczkowski, S. J. W., Levy, M. M., Derde, L. P. G., Dzierba, A. L., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,578
Self-citation
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,304
Self-citation
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 663
Self-citation
Early prediction of circulatory failure in the intensive care unit using machine learning
Hyland, S. L., Faltys, M., Hüser, M., Lyu, X., Gumbsch, T., Esteban, C., Bock, C., Horn, M., Moor, M., Rieck, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0789-4 · Cited by 477
Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
Busse, L. W., Barker, N. A., & Petersen, C. (2020) · Critical Care · doi:10.1186/s13054-020-2743-8 · Cited by 242
Current use of vasopressors in septic shock
Scheeren, T., Bakker, J., Backer, D. D., Annane, D., Asfar, P., Boerma, E. C., Cecconi, M., Dubín, A., Dünser, M. W., Duranteau, J., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0498-7 · Cited by 204
Self-citation
O Coração e a COVID-19: O que o Cardiologista Precisa Saber
Costa, I. B. S. D. S., Bittar, C. S., Rizk, S. I., de Araújo, A. E., dos Santos, K. K. M., Machado, T. I. V., Andrade, F. T. D. A., González, T. B., Arévalo, A. N. G., de Almeida, J. P., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200279 · Cited by 194
Self-citation
Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials
Nagendran, M., Russell, J. A., Walley, K. R., Brett, S. J., Perkins, G. D., Hajjar, L., Mason, A. J., Ashby, D., & Gordon, A. C. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05620-2 · Cited by 161
Self-citation
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations
Nanchal, R. S., Subramanian, R., Karvellas, C. J., Hollenberg, S. M., Peppard, W. J., Singbartl, K., Truwit, J. D., Al-Khafaji, A. H., Killian, A. J., Alquraini, M., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004192 · Cited by 160
Self-citation
Vasopressin and its analogues in shock states: a review
Demiselle, J., Fage, N., Radermacher, P., & Asfar, P. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0628-2 · Cited by 137
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock*
Sacha, G. L., Lam, S. W., Wang, L., Duggal, A., Reddy, A. J., & Bauer, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005317 · Cited by 135
Intensive care management of patients with COVID-19: a practical approach
Hajjar, L. A., Costa, I. B. S. D. S., Rizk, S. I., Biselli, B., Gomes, B. R., Bittar, C. S., de Oliveira, G. Q., de Almeida, J. P., Bello, M. V. D. O., Garzillo, C. L., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00820-w · Cited by 141
Self-citation
Vasopressors in septic shock: which, when, and how much?
Shi, R., Hamzaoui, O., Vita, N. D., Monnet, X., & Teboul, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.24 · Cited by 126
Early Care of Adults With Suspected Sepsis in the Emergency Department and Out-of-Hospital Environment: A Consensus-Based Task Force Report
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 123
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art
Hajjar, L. A., & Teboul, J. (2019) · Critical Care · doi:10.1186/s13054-019-2368-y · Cited by 92
Self-citation
Vasopressor Therapy in the Intensive Care Unit
Russell, J. A., Gordon, A. C., Williams, M. D., Boyd, J. H., Walley, K. R., & Kissoon, N. “. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710320 · Cited by 99
Self-citation
Right Heart Failure in Pulmonary Hypertension
Cassady, S. J., & Ramani, G. V. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.02.001 · Cited by 88
Vasopressor Therapy in Cardiac Surgery—An Experts’ Consensus Statement
Guarracino, F., Habicher, M., Treskatsch, S., Sander, M., Székely, A. D., Paternoster, G., Salvi, L., Łysenko, L., Gaudard, P., Giannakopoulos, P., et al. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.11.032 · Cited by 84
Self-citation
Vasopressor and Inotrope Therapy in Cardiac Critical Care
Jentzer, J. C., & Hollenberg, S. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620917630 · Cited by 77
Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
Ltaief, Z., Ben‐Hamouda, N., Rancati, V., Gunga, Z., Marcucci, C., Kirsch, M. E. W., & Liaudet, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216407 · Cited by 74
Atrial fibrillation detected initially during acute medical illness: A systematic review
McIntyre, W. F., Um, K. J., Cheung, C. C., Belley‐Côté, E. P., Dingwall, O., Devereaux, P. J., Wong, J. A., Conen, D., Whitlock, R. P., Connolly, S. J., et al. (2018) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872618799748 · Cited by 64
Self-citation
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial*
Hajjar, L. A., Zambolim, C. M., Belletti, A., de Almeida, J. P., Gordon, A. C., Oliveira, G., Park, C. H. L., Fukushima, J. T., Rizk, S. I., Szeles, T. F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004023 · Cited by 63
Self-citation
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Shankar, A., Gurumurthy, G., Sridharan, L., Gupta, D., Nicholson, W. J., Jaber, W. A., & Vallabhajosyula, S. (2022) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468221075064 · Cited by 53
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 61
Association between acute kidney injury and norepinephrine use following cardiac surgery: a retrospective propensity score-weighted analysis
Huette, P., Moussa, M. D., Beyls, C., Guinot, P., Guilbart, M., Besserve, P., Bouhlal, M., Mounjid, S., Dupont, H., Mahjoub, Y., et al. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01037-1 · Cited by 52
Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions
Lesur, O., Delile, E., Asfar, P., & Radermacher, P. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0449-8 · Cited by 53
Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases
Xu, J., Cai, H., & Zheng, X. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08147-6 · Cited by 45
Vasoactive Agent Use in Septic Shock: Beyond First‐Line Recommendations
Sacha, G. L., Bauer, S. R., & Lat, I. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2220 · Cited by 40
The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis
Jiang, L., Sheng, Y., Feng, X., & Wu, J. (2019) · Critical Care · doi:10.1186/s13054-019-2362-4 · Cited by 40
Atrial Fibrillation: Current Evidence and Management Strategies During the Perioperative Period
Karamchandani, K., Khanna, A. K., Bose, S., Fernando, R. J., & Walkey, A. J. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004474 · Cited by 37
Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous‐Flow Left Ventricular Assist Devices
Asleh, R., Alnsasra, H., Daly, R. C., Schettle, S. D., Briasoulis, Α., Taher, R., Dunlay, S. M., Stulak, J. M., Behfar, A., Pereira, N. L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013108 · Cited by 37
ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock
Leisman, D. E., Handisides, D. R., Busse, L. W., Chappell, M. C., Chawla, L. S., Filbin, M. R., Goldberg, M. B., Ham, K. R., Khanna, A. K., Ostermann, M., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04910-6 · Cited by 37
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?
Lajoye, Q., Orieux, A., Boyer, A., Prével, R., & Jozwiak, M. (2025) · Critical Care · doi:10.1186/s13054-025-05540-2 · Cited by 38
Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study*
Martin, G. L., Trioux, T., Gaudry, S., Tubach, F., Hajage, D., & Dechartres, A. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005065 · Cited by 22
Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials
Nedel, W. L., Rech, T. H., Ribeiro, R. A., Pellegrini, J. A. S., & Moraes, R. B. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003471 · Cited by 32
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis
McIntyre, W. F., Vadakken, M. E., Rai, A. S., Thach, T., Syed, W., Um, K. J., Ibrahim, O., Dalmia, S., Bhatnagar, A., Mendoza, P. A., et al. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-021-01944-0 · Cited by 35
Self-citation
Vasoplegia: A Review
Ratnani, I., Ochani, R. K., Shaikh, A., & Jatoi, H. N. (2023) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1245 · Cited by 33
Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial
Balík, M., Malý, M., Brožek, T., Rulíšek, J., Pořízka, M., Šachl, R., Otáhal, M., Brestovansky, P., Svobodová, E., Flaksa, M., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07208-3 · Cited by 31
Predictors of dysrhythmias with norepinephrine use in septic shock
Wieruszewski, E. D., Jones, G. M., Samarin, M. J., & Kimmons, L. A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.10.023 · Cited by 34
Vasopressors to treat refractory septic shock
Meresse, Z., Medam, S., Mathieu, C., Duclos, G., Vincent, J., & Léone, M. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.13826-4 · Cited by 33
Optimizing Vasopressin Use and Initiation Timing in Septic Shock
Sacha, G. L., & Bauer, S. R. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.07.009 · Cited by 31
THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS
Jia, L., Wang, P., Li, C., & Xie, J. (2023) · Shock · doi:10.1097/shk.0000000000002193 · Cited by 31
Vasopressin in Sepsis and Other Shock States: State of the Art
García-Álvarez, R., & Arboleda-Salazar, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111548 · Cited by 33
Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness
McIntyre, W. F., Vadakken, M. E., Connolly, S. J., Mendoza, P. A., Lengyel, A. P., Rai, A. S., Latendresse, N. R., Grinvalds, A., Ramasundarahettige, C. F., Acosta, J. G., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-1411 · Cited by 30
Self-citation
Expert consensus on blood pressure management in critically ill patients
Yu, Y., Gong, Y., Hu, B., Ouyang, B., Pan, A., Liu, J., Liu, F., Shang, X., Yang, X., Tu, G.-W., et al. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.06.001 · Cited by 32
Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery
Suero, O. R., Park, Y., Wieruszewski, P. M., & Chatterjee, S. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.06.002 · Cited by 28
Vasopressor use in cardiogenic shock
Lévy, B., Klein, T., & Kimmoun, A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000743 · Cited by 28
Mean Arterial Pressure Targets and Patient-Important Outcomes in Critically Ill Adults: A Systematic Review and Meta-Analysis of Randomized Trials*
Carayannopoulos, K. L., Pidutti, A., Upadhyaya, Y., Alshamsi, F. E., Basmaji, J., Granholm, A., Alhazzani, W. A., & Lewis, K. A. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005726 · Cited by 29
Self-citation
Ten tips to optimize vasopressors use in the critically ill patient with hypotension
Legrand, M. M., & Zarbock, A. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06708-y · Cited by 31
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 29
Comparison of Heart Rate After Phenylephrine vs Norepinephrine Initiation in Patients With Septic Shock and Atrial Fibrillation
Law, A. C., Bosch, N. A., Peterson, D., & Walkey, A. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.04.147 · Cited by 26
Alternatives to norepinephrine in septic shock: Which agents and when?
Jozwiak, M. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.05.001 · Cited by 27
Role of Ischemia/Reperfusion and Oxidative Stress in Shock State
Vázquez-Galán, Y. I., Guzmán-Silahua, S., Trujillo-Rangel, W. Á., & Rodríguez-Lara, S. Q. (2025) · Cells · doi:10.3390/cells14110808 · Cited by 29
Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials
Kotani, Y., Belletti, A., D’Amico, F., Bonaccorso, A., Wieruszewski, P. M., Fujii, T., Khanna, A. K., Landoni, G., & Bellomo, R. (2024) · Critical Care · doi:10.1186/s13054-024-05212-7 · Cited by 25
Terlipressin for septic shock patients: a meta-analysis of randomized controlled study
Zhu, Y., Huang, H., Xi, X., & Du, B. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0369-1 · Cited by 24
Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock*
Sacha, G. L., Kiser, T. H., Wright, G. C., Vandivier, R. W., Moss, M., Burnham, E. L., Ho, P. M., Reynolds, P., & Bauer, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005305 · Cited by 23
How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock
Teja, B. J., Bosch, N. A., & Walkey, A. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.019 · Cited by 26
Echocardiographic profiles and hemodynamic response after vasopressin initiation in septic shock: A cross-sectional study
Dugar, S. P., Siuba, M., Sacha, G. L., Sato, R., Moghekar, A., Collier, P. H., Grimm, R. A., Vachharajani, V., & Bauer, S. R. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154298 · Cited by 24
Cost-effectiveness of second-line vasopressors for the treatment of septic shock
Lam, S. W., Barreto, E. F., Scott, R. A., KASHANI, K. B., Khanna, A. K., & Bauer, S. R. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.10.005 · Cited by 22
Association of Premorbid Blood Pressure with Vasopressor Infusion Duration in Patients with Shock
Gershengorn, H. B., Stelfox, H. T., Niven, D. J., & Wunsch, H. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1681oc · Cited by 22
Atrial fibrillation in critical illness: state of the art
Sibley, S. R., Bedford, J., Wetterslev, M., Johnston, B. W., Garside, T., Kanji, S., Whitehouse, T., Welters, I. D., Ostermann, M., Balík, M., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07895-0 · Cited by 21
Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey
Jozwiak, M., Cousin, V. L., Backer, D. D., Malbrain, M. L. N. G., Monnet, X., Messina, A., Chew, M. S., & the Cardiovascular Dynamics section of the European Society of Intensive Care Medicine (2025) · Critical Care · doi:10.1186/s13054-025-05505-5 · Cited by 22
Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock
Honarmand, K., Um, K. J., Belley‐Côté, E. P., Alhazzani, W. A., Farley, C., Fernando, S. M., Fiest, K. M., Grey, D., Hajdini, E., Herridge, M. S., et al. (2019) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-019-01546-x · Cited by 20
Self-citation
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009
Benea, C., Turner, K. A., Roseman, M., Bero, L. A., Lexchin, J., Turner, E. H., & Thombs, B. D. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01318-5 · Cited by 23
Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis
Fernando, S. M., Tran, A., Soliman, K., Flynn, B., Oommen, T., Li, W., Adhikari, N. K. J., Kanji, S., SEELY, A. J. E., Fox‐Robichaud, A., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001110 · Cited by 21
Self-citation
Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States
Bosch, N. A., Teja, B. J., Wunsch, H., & Walkey, A. J. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-196oc · Cited by 19
Sepsis in 2018: a review
Wentowski, C. C., Mewada, N., & Nielsen, N. D. (2018) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2018.11.009 · Cited by 21
Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock
Jakowenko, N. D., Murata, J., Kopp, B. J., & Erstad, B. L. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221081836 · Cited by 18
Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review
Ortoleva, J. P., Dalia, A. A., Convissar, D. L., Pisano, D. V., Bittner, E. A., & Berra, L. M. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.01.012 · Cited by 18
Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion
Liu, S., Meng, Q., Xu, Y., & Zhou, J. (2021) · Gastroenterology report · doi:10.1093/gastro/goab040 · Cited by 17
Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
Muhammad, R., Dharmadjati, B. B., Mulia, E. P. B., & Rachmi, D. A. (2022) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2022.20394 · Cited by 18
Focus on sepsis
Møller, M. H., Alhazzani, W., & Shankar-Hari, M. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05680-4 · Cited by 17
Self-citation
Haemodynamic management of septic shock
Kotani, Y., Ryan, N., Udy, A. A., & Fujii, T. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae081 · Cited by 18
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock
Leisman, D. E., Wieruszewski, P. M., Busse, L. W., Chawla, L. S., Hibbert, K. A., Handisides, D. R., Khanna, A. K., Ostermann, M., McCurdy, M. T., Adams, C., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05311-z · Cited by 16
Early management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 16
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow‐up cohort study
McIntyre, W. F., Mendoza, P. A., Belley‐Côté, E. P., Whitlock, R. P., Um, K. J., Майстренко, Н. С., Devereaux, P. J., Conen, D., Wong, J. A., Connolly, S. J., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.23053 · Cited by 15
Self-citation
Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
Yao, R.-Q., Xia, D., Wang, L., Wu, G., Zhu, Y., Zhao, H., Liu, Q., Xia, Z., Ren, C., & Yao, Y.-M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00563 · Cited by 17
Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies
Heavner, M. S., McCurdy, M. T., Mazzeffi, M. A., Galvagno, S. M., Tanaka, K. A., & Chow, J. H. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620911601 · Cited by 16
Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock
Bauer, S. R., Sacha, G. L., Lam, S. W., Wang, L., Reddy, A. J., Duggal, A., & Vachharajani, V. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620977181 · Cited by 15
Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial
Bokoch, M. P., Tran, A. T., Brinson, E. L., Marcus, S. G., Reddy, M., Sun, E., Roll, G. R., Pardo, M., Fields, S., Adelmann, D., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-078713 · Cited by 16
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art
Hajjar, L. A., & Teboul, J. (2019) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-06067-1_13 · Cited by 16
Self-citation
General Critical Care, Temperature Control, and End-of-Life Decision Making in Patients Resuscitated from Cardiac Arrest
Chalkias, A. F., Adamos, G., & Mentzelopoulos, S. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124118 · Cited by 15
Sepsis in 2024: a review
Wayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 16
Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study
Melchers, M., de Smet, V., Rooijakkers, C., Huising, J., Vermeulen, W., Köktaş, B. N. N., van de Vusse, K. J., Sabzewar, K. M., Mishra, S. B., Bethlehem, C., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01472-w · Cited by 14
Clinical course after identification of new-onset atrial fibrillation in critically ill patients: The AFTER-ICU study
Yoshida, T., Uchino, S., & Sasabuchi, Y. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.06.014 · Cited by 14
Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock
Khalique, S. C., & Ferguson, N. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000247 · Cited by 14
Outcomes and Management of Stressor-Associated Atrial Fibrillation
Haimovich, J. S., Kany, S., Ajufo, E. C., Andrade, J. G., Benjamin, E. J., Healey, J. S., Kirchhof, P. F., Lubitz, S. A., McIntyre, W. F., Rienstra, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.031 · Cited by 13
Self-citation
Risk factors for new-onset atrial fibrillation during critical illness: A Delphi study
Bedford, J. P., Garside, T., Darbyshire, J., Betts, T., Young, J. D., & Watkinson, P. (2021) · Journal of the Intensive Care Society · doi:10.1177/17511437211022132 · Cited by 11
Evaluation of the Addition of Angiotensin II in Patients With Shock After Cardiac Surgery at a Veterans Affairs Medical Center
Bird, S., Chand, M., Tran, T. L., Ali, S., Awad, S. S., Cornwell, L. D., Schütz, A., & Jiménez, E. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221099928 · Cited by 13
Therapeutic Dilemmas in Mixed Septic-Cardiogenic Shock
Jassir, D. U., Chaanine, A. H., Desai, S., Rajapreyar, I. N., & Jemtel, T. H. L. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.09.022 · Cited by 14
High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients
McIntyre, W. F., Belley‐Côté, E. P., Vadakken, M. E., Rai, A. S., Lengyel, A. P., Rochwerg, B. N., Bhatnagar, A., Deif, B., Um, K. J., Spence, J. D., et al. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000311 · Cited by 13
Self-citation
A Clinical Review of Vasopressors in Emergency Medicine
Stampfl, M. J., & DeBlieux, P. M. C. (2024) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2024.03.004 · Cited by 18
Vasopressin in vasoplegic shock: A systematic review
Webb, A. J., Seisa, M. O., Nayfeh, T., Wieruszewski, P. M., Nei, S. D., & Smischney, N. J. (2020) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v9.i5.88 · Cited by 12
Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock
Menich, B. E., Miano, T. A., Patel, G. P., & Hammond, D. A. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019843664 · Cited by 14
ANGIOTENSIN II IN THE TREATMENT OF DISTRIBUTIVE SHOCK: A SYSTEMATIC-REVIEW AND META-ANALYSIS
Xourgia, E., Exadaktylos, A. K., Chalkias, A. F., & Ziaka, M. (2024) · Shock · doi:10.1097/shk.0000000000002384 · Cited by 11
Terlipressin or norepinephrine, or both in septic shock?
Mårtensson, J., & Gordon, A. C. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5290-x · Cited by 11
Self-citation
Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial)
Guinot, P., Desebbe, O., Besch, G., Guerci, P., Gaudard, P., Lena, D., Mertès, P., Arab, O. A., Bouhemad, B., Nguyen, M., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.03.008 · Cited by 11

Authors: McIntyre, W. F., Um, K. J., Alhazzani, W., Lengyel, A. P., Hajjar, L., Gordon, A. C., Lamontagne, F., Healey, J. S., Whitlock, R. P., & Belley-Côté, E. P.
Affiliations: McMaster University (CA)
Universidade de São Paulo (BR)
Charing Cross Hospital (GB)
Université de Sherbrooke (CA)
McMaster University, Hamilton, Ontario, Canada
ORCID: McIntyre, William F.
Um, Kevin J.
Alhazzani, Waleed
Hajjar, Ludhmila
Gordon, Anthony C.
Lamontagne, François
Healey, Jeff S.
Whitlock, Richard P.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2018-05-08
Volume: 319
Issue: 18
Pages: 1889
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2018.4528
PMC: PMC6583502
OpenAlex: W2802319261
Cited by: 225
References: 45
Citations by year: 2026: 27 · 2025: 28 · 2024: 28 · 2023: 27 · 2022: 29 · 2021: 20 · 2020: 37 · 2019: 20 · 2018: 9
FWCI: 16.77
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: JAMA (publishedVersion, other-oa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Spiral (Imperial College London) (submittedVersion)
Funders: National Institute for Health and Care Research (NIHR/CS/009/007, PB-PG-0610-22350)
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: vasopressin, distributive shock, septic shock, atrial fibrillation, mortality, renal replacement therapy, myocardial injury, ventricular arrhythmias, stroke, length of hospital stay, intensive care unit, sepsis, vasodilation, myocardial oxygen demand, fluid resuscitation, vasopressor combination
MeSH terms: Atrial Fibrillation, Catecholamines, Drug Therapy, Combination, Female, Humans, Length of Stay, Male, Shock, Vasoconstrictor Agents, Vasopressins, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks